de Jong FH - Search Results

1

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.

Alexieva-Figusch J, Blankenstein MA, Hop WC, Klijn JG, Lamberts SW, de Jong FH, Docter R, Adlercreutz H, van Gilse HA. Alexieva-Figusch J, et al. Among authors: de jong fh. Eur J Cancer Clin Oncol. 1984 Jan;20(1):33-40. doi: 10.1016/0277-5379(84)90031-2. Eur J Cancer Clin Oncol. 1984. PMID: 6363095 Clinical Trial.

2

Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer.

Alexieva-Figusch J, de Jong FH, Lamberts WJ, van Gilse HA, Klign JG. Alexieva-Figusch J, et al. Among authors: de jong fh. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1349-56. doi: 10.1016/0277-5379(87)90119-2. Eur J Cancer Clin Oncol. 1987. PMID: 2960533

3

LHRH-agonist treatment in metastatic prostate carcinoma.

Klijn JG, de Jong FH, Lamberts SW, Blankenstein MA. Klijn JG, et al. Among authors: de jong fh. Eur J Cancer Clin Oncol. 1984 Apr;20(4):483-93. doi: 10.1016/0277-5379(84)90233-5. Eur J Cancer Clin Oncol. 1984. PMID: 6426968

4

Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.

Alexieva-Figusch J, Blankenstein MA, de Jong FH, Lamberts SW. Alexieva-Figusch J, et al. Among authors: de jong fh. Eur J Cancer Clin Oncol. 1984 Sep;20(9):135-40. doi: 10.1016/0277-5379(84)90121-4. Eur J Cancer Clin Oncol. 1984. PMID: 6434315

5

Antiprogestins, a new form of endocrine therapy for human breast cancer.

Klijn JG, de Jong FH, Bakker GH, Lamberts SW, Rodenburg CJ, Alexieva-Figusch J. Klijn JG, et al. Among authors: de jong fh. Cancer Res. 1989 Jun 1;49(11):2851-6. Cancer Res. 1989. PMID: 2720645

6

Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.

Bakker GH, Setyono-Han B, Henkelman MS, de Jong FH, Lamberts SW, van der Schoot P, Klijn JG. Bakker GH, et al. Among authors: de jong fh. Cancer Treat Rep. 1987 Nov;71(11):1021-7. Cancer Treat Rep. 1987. PMID: 3119199

7

LHRH-agonist treatment in clinical and experimental human breast cancer.

Klijn JG, de Jong FH, Lamberts SW, Blankenstein MA. Klijn JG, et al. Among authors: de jong fh. J Steroid Biochem. 1985 Nov;23(5B):867-73. doi: 10.1016/s0022-4731(85)80029-7. J Steroid Biochem. 1985. PMID: 3935869 Clinical Trial.

8

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.

Klijn JG, de Jong FH. Klijn JG, et al. Among authors: de jong fh. Lancet. 1982 May 29;1(8283):1213-6. doi: 10.1016/s0140-6736(82)92339-x. Lancet. 1982. PMID: 6122975

9

Effects of megestrol acetate on growth and secretion of a pituitary tumor.

Lamberts SW, Janssens EN, Bons EG, Zuiderwijk JM, Uitterlinden P, de Jong FH. Lamberts SW, et al. Among authors: de jong fh. Eur J Cancer Clin Oncol. 1981 Aug;17(8):925-31. doi: 10.1016/0014-2964(81)90316-9. Eur J Cancer Clin Oncol. 1981. PMID: 6276184 No abstract available.

10

Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.

Klijn JG, de Jong FH, Blankenstein MA, Docter R, Alexieva-Figusch J, Blonk-van der Wijst J, Lamberts SW. Klijn JG, et al. Among authors: de jong fh. Breast Cancer Res Treat. 1984;4(3):209-20. doi: 10.1007/BF01806487. Breast Cancer Res Treat. 1984. PMID: 6435703 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters